NCT00564642 Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity Status COMPLETED Phase NA
NCT00560521 Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion Status COMPLETED Phase NA
NCT00557765 Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area Status COMPLETED Phase N/A
NCT00546273 Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00541294 Diagnosis of Tuberculosis Infection in HIV Co-infected Children Status COMPLETED Phase N/A
NCT00533390 Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg Status TERMINATED Phase PHASE4
NCT00523926 TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis Status COMPLETED Phase PHASE2
NCT00523458 A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV Status TERMINATED Phase PHASE4
NCT00512330 Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB) Status UNKNOWN Phase N/A
NCT00495651 Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) Status COMPLETED Phase PHASE3
NCT00495326 Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) Status COMPLETED Phase PHASE2/PHASE3
NCT00491933 Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists Status UNKNOWN Phase NA
NCT00483054 Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin Status COMPLETED Phase PHASE3
NCT00476853 Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy Status COMPLETED Phase PHASE2
NCT00474435 Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis Status UNKNOWN Phase PHASE2
NCT00465465 A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCG Status COMPLETED Phase PHASE1